Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

1ST Bio Bets On BBB-Penetrating C-ABL Inhibitor As Potential Disease-Modifying Parkinson's Drug

Jun 01 2018

• By Jung Won Shin

Related Companies

Sun Pharma Advanced Research Company Ltd.

Novartis AG

Johns Hopkins University

Handok

Sanofi

Pfizer Inc.

Wyeth

Additional Topics

South Korea Asia Pacific StartUps and SMEs Research & Development Neurology Cancer BioPharmaceutical

More from South Korea

More from Focus On Asia

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.